Close Menu

immune system diseases

The companies anticipate launching the next-generation sequencing-based tests in Russia "in the near future."

Researchers involved with the WGS500 study reported on findings from more than 150 clinical cases assessed by whole-genome sequencing.

Sequencing on samples from individuals in a previously uncontacted Venezuelan tribe pointed to extraordinarily diverse gut and skin microbiomes.

The Uppsala University study recommends a targeted sequencing assay as a first-line test to diagnose primary immunodeficiency disorders.

NEW YORK (GenomeWeb) – The National Institute of Health will award up to $3.4 million next year to fund genomics research programs and projects aimed at better understanding how two complex human genomic regions are involved in a range of immune system diseases.

NEW YORK (GenomeWeb News) – Bioanalytical testing company Eurofins Scientific today said it has signed a definitive agreement to purchase esoteric reference laboratory ViraCor-IBT Laboratories for about $255 million.

NEW YORK (GenomeWeb News) — Exosome Diagnostics said today that it has entered into a collaboration agreement with Eli Lilly for biomarker discovery and validation using Exosome's EXO50 nucleic acid extraction kit.

NEW YORK (GenomeWeb News) – ImaginAb, a Los Angeles-based developer of molecular imaging agents, has entered into an alliance with MacroGenics to develop companion imaging agents for an anti-cancer drug being developed by the Rockville, Md.-based biotech firm.

By Monica Heger
SHENZHEN, China — BGI and Sweden's Karolinska Institute University Hospital plan to develop an immunogenetics center based in BGI's hometown.

Pages

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.